Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research
- PMID: 19630745
- PMCID: PMC6167747
- DOI: 10.2174/1874473710902020143
Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research
Abstract
Neuropsychological dysfunction, ranging from mild cognitive symptoms to dementia has been a consistent part of the clinical picture of HIV/AIDS. However, advances in clinical management, particularly antiretroviral (ARV) treatment, have mitigated the neuropsychological effects of HIV and revised the pattern and nature of cognitive deficits, which are observed in HIV-infected individuals. The attendant improvements in mortality and morbidity have led to a need for programs and interventions that sustain healthy behavior and prevent a resurgence of HIV transmission risk. Psychiatric risk factors, particularly substance use, which often contribute to initial acquisition of HIV, still require attention. These risk factors may also exacerbate neuropsychological dysfunction and compromise adherence to prevention recommendations and treatment. Specifically, a more complete understanding of the effects of substance abuse on the progression of HIV related cognitive decline can inform evaluation and management of HIV seropositives with concurrent substance use disorders. This review provides an overview of the neuropsychology of HIV and substance abuse and the extant research that has examined the effects of both HIV disease and substance use on neuropsychological functioning and implications for treatment and future research.
Similar articles
-
An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.Curr Drug Abuse Rev. 2015;8(1):50-71. doi: 10.2174/1874473708666150309124820. Curr Drug Abuse Rev. 2015. PMID: 25751583 Free PMC article. Review.
-
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.AIDS. 2004 Jan 1;18 Suppl 1(Suppl 1):S19-25. doi: 10.1097/00002030-200418001-00004. AIDS. 2004. PMID: 15075494 Free PMC article.
-
The Important Role of Mental Illness and Substance Abuse in Successful Management of HIV Infection.J Assoc Nurses AIDS Care. 2017 Mar-Apr;28(2):181-184. doi: 10.1016/j.jana.2017.01.002. J Assoc Nurses AIDS Care. 2017. PMID: 28236902 No abstract available.
-
Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.AIDS Care. 2009 Feb;21(2):168-77. doi: 10.1080/09540120802001705. AIDS Care. 2009. PMID: 19229685 Free PMC article.
-
Neuropsychiatric aspects of HIV infection among older adults.J Clin Epidemiol. 2001 Dec;54 Suppl 1(Suppl 1):S44-52. doi: 10.1016/s0895-4356(01)00446-2. J Clin Epidemiol. 2001. PMID: 11750209 Free PMC article. Review.
Cited by
-
Substance Use and Discrimination in a Sample of U.S.-Based Latinx Sexual Minority Men and Their Main Partners.J Stud Alcohol Drugs. 2024 Nov;85(6):867-876. doi: 10.15288/jsad.23-00170. Epub 2024 May 22. J Stud Alcohol Drugs. 2024. PMID: 38775316
-
Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study.J Clin Exp Neuropsychol. 2010 Jun;32(5):474-80. doi: 10.1080/13803390903201769. Epub 2009 Nov 24. J Clin Exp Neuropsychol. 2010. PMID: 19937504 Free PMC article. Clinical Trial.
-
Neurocognitive impairment and HIV risk factors: a reciprocal relationship.AIDS Behav. 2010 Dec;14(6):1213-26. doi: 10.1007/s10461-010-9684-1. AIDS Behav. 2010. PMID: 20232242 Free PMC article. Review.
-
Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats.Pharmacol Biochem Behav. 2011 Jun;98(4):587-97. doi: 10.1016/j.pbb.2011.03.013. Epub 2011 Mar 21. Pharmacol Biochem Behav. 2011. PMID: 21420997 Free PMC article.
-
HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats.Nicotine Tob Res. 2017 Sep 1;19(9):1024-1032. doi: 10.1093/ntr/ntx047. Nicotine Tob Res. 2017. PMID: 28339662 Free PMC article.
References
-
- UNAIDS, 2006. AIDS Epidemic Update – December 2006. Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland. - PubMed
-
- Martin EM, Nixon H, Pitrak DL, et al. Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp Nueropsychol 2007; 29(5): 496–504. - PubMed
-
- Kopnisky KL, Bao J, Lin YW. Neurobiology of HIV, psychiatric and substance abuse comorbidity research: Workshop report. Brain Behav Immun 2007; 21: 428–41. - PubMed
-
- Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5: 69–81. - PubMed